Ignite Creation Date:
2024-05-06 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05070754
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2021-09-27
Brief Title:
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
Using a Cold Atmospheric Plasma Device to Treat Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is going to test a cold atmospheric plasma device CAP in particular a floating electrode-dielectric barrier device FE-DBD to treat warts and molluscum The treatment device in this study generates cold atmospheric plasma gaseous ionized molecules to rid the virus from the body Based on the successes of previous dermatologic studies FE-DBD is being tested for this study to treat warts and molluscum Patients will be enrolled to test the efficacy and safety of this device The duration of the study is 4-12 weeks depending on treatment clearance The number of lesions will be chosen by the dermatologist Patients will receive standard of care therapy andor NTAP depending on the number of lesions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None